Cytotoxic T-cell antagonism in HIV-1

Seminars in Virology

Volumn 7, Issue 1, 1996, Pages 31-39

  Klenerman, Paul ^a   Phillips, Rodney ^a   McMichael, Andrew ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Altered peptide ligand; Antagonism; CTL; HIV 1; T cell receptor

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERSISTENT VIRUS INFECTION; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029966319     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1996.0005     Document Type: Review

References (61)

1. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT (1987) HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345-348
2. Nixon DF, Townsend ARM, Elvin JG, Rizza CR, Gallwey J, McMichael AJ (1988) HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484-487
3. Plata F, Autran B, Martins LP, Wain-Hobson S, Raphael M, Mayaud C, Denis M, Guillon JM, Debre P (1987) AIDS virus specific cytotoxic T lymphocytes in lung disorders. Nature 328:348-351
4. Hu W, Temin H (1990) Retroviral recombination and reverse transcription. Science 250:1227-1233
5. Goodenow M, Huet T, Saurin W (1989) HIV-1 isolates are a rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J AIDS 2:344-352
6. Pircher H, Moskphidis A, Rohrer U, Burki K, Hengartner H, Zinkernagel RM (1990) Viral escape by selection of cytotoxic T cell-resistant variants in vivo. Nature 346:629-633
7. Townsend A, Bodmer H (1989) Antigen recognition by class I-restricted cytotoxic T lymphocytes. Ann Rev Immunol 7:601-624
8. Kagi D, Ledermann B, Burki K, Zinkernagel R, Hentgartner H (1994) Cytotoxicity mediated by CTL and NK cells is greatly impaired in perform deficient mice. Nature 369:31-37
9. Evavold B, Sloan-Lancaster J, Allen P (1993) Tickling the TCR: selective T cell functions stimulated by APL. Immunol Today 14:602-609
10. Safrit J, Andrews C, Zhu T, Ho D, Koup R (1994) Characterisation of HIV-1 CTL clones isolated during acute seroconversion. J Exp Med 179:463-472
11. Pantaleo G, Demarest J, Soudyens H, Graziosi C, Denis F, Adelsberger J, Borrow P, Saag M, Shaw G, Sekaly R, Fauci A (1994) Major expansion of CD8 cells with a predominant v-beta usage during the primary immune response to HIV. Nature 370:463-467
12. Carmichael A, Jin X, Sissons P, Borysiewicz L (1993) Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 177:249-256
13. Walker BD, Flexner C, Paradis TJ, Fuller TC, Hirsch MS, Schooley RT, Moss B (1988) HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240
14. Culmann B, Gomard E, Kieny M-P, Guy B, Dreyfus F, Saimot A-G, Sereni D, Levy J-P (1989) An antigenic peptide of HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. Eur J Immunol 19:2383-2386
15. Culmann B, Gomard E, Kieny M-P (1991) Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 nef protein. J Immunol 146:1560-1565
16. Lamhamedi CS, Culmann PB, Guy B, Kieny MP, Dreyfus F, Saimot AG, Sereni D, Sicard D, Levy JP, Gomard E (1992) Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS 6:1249-1258
17. McMichael A, Walker B (1994) CTL epitopes: implications for AIDS vaccines. AIDS 8:S155-S173
18. Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo S, D'Aquila RT, Kurnick JT, Kurnick BDW (1994) Longitudinal analysis of HIV env specific clones reveals a limited TCR usage. J Exp Med 179:1261-1210
19. Gavioli R, Kurilla MG, de CLP, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG (1993) Multiple HLA All-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol 67:1572-1578
20. Moss PAH, Rowland-Jones SL, Frodsham PM, McMichael AJ, Bell JI (1995) Very high frequency and long-term persistence of HIV-specific CTL in peripheral blood of infected donors. Proc Natl Acad Sci (USA) in press
21. Moskophidis D, Lechner F, Hentgartner H, Zinkernagel R (1994) Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral CTL. Nature 362:758-762
22. Grant MD, Smaill FM, Singal DP, Rosenthal KL (1992) The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1 infected subjects. AIDS 6:1085-1094
23. Buseyne F, Blanche S, Schmitt D, Griscelli C, Riviere Y (1993) Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. J Immunol 150:3569-3581
24. Ho D, Neumann, Perelson A, Chen W, Leonard J, Makowitz M (1995) Rapid turnover of plasma virions in HIV-1 infection. Nature 373:123-126
25. Wei X, Gosh S, Taylor M, Johnson V, Emini E, Deutsch P, Lifson J, Bonhoeffer S, Nowak M, Hahn B, Saag M, Shaw G (1995) Viral dynamics in HIV-1 infection. Nature 373:117-122
26. Embretson J, Zupanic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359-362
27. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993) HIVinfection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358
28. Cerundolo V, Tse AGD, Salter RD, Parham P, Townsend A (1991) CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA Aw68.1. Proc R Soc Lond B 244:169-177
29. Del Val M, Schlicht H-J, Ruppert T, Reddenhase MJ, Koszinowski U (1991) Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighbouring residues in the protein. Cell 66:1145-1153
30. Bergman C, Tong L, Racquel C, Sensistaffou J, Stohlam S (1994) Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J Virol 68:5306-5310
31. Phillips RE, Rowland-Jones SL, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR et al (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition [see comments]. Nature 354:453-459
32. Howcroft T, Strebel K, Martin M, Singer D (1993) Repression of MHC Class I gene promoter activity by 2 exon tat of HIV. Science 260:1320-1322
33. Coullin I, Culmann-Penciolelli B, Gomard E, Levy J-P, Guillet J-G, Saragosti S (1994) Impaired CTL recognition due to genetic variations in the main immunogenic region of the HIV-1 nef protein. J Exp Med 180:1129-1134
34. McAdam S, Klenerman P, Tussey L, Lalloo D, Phillips R, Giangrande P, Edwards A, Leigh-Brown A, Gotch F, McMichael A (1995) Immunogenic HIV peptides which bind HLA-B8 but fail to stimulate CLT responses. J Immunol 155:2729-2736
35. De Campos Lima P, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, Rowe M, Rickinson AB, Masucci MG (1993) HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 260:98-100
36. Moskophidis D, Zinkernagel R (1995) Immunobiology of CTL escape mutants of LCMV. J Virol 69:2187-2193
37. Jameson S, Sevan M (1995) TCR antagonists and partial agonists. Immunity 2:1-11
38. Sette A, Alexander J, Ruppert J, Snoke K, Franco A, Ishioka G, Grey H (1993) Antigen analogs/MHC complexes as specific TCR antagonists. Annu Rev Immunol 12:413-432
39. Evavold B, Allen P (1991) Separation of IL4 production from proliferation by an altered TCR ligand. Science 252:1308-1310
40. Racioppi L, Ronchese F, Matis L, Germain R (1993) Peptide-MHC Class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in TCR dependent intracellular signalling. J Exp Med 177:1047-1060
41. De Magistris M, Alexander J, Coggeshall M, Altmann A, Gaeta F, Grey H, Sette A (1992) Antigen analog-major histocompatibility complexes act as antagonists of the TCR. Cell 68:625-634
42. Alexander J, Snoke K, Ruppert J, Sidney J, Wall M, Southwood S, Oseroff C, Arrhenius T, Gaeta F, Colon S, Grey H, Sette A (1993) Functional consequences of engagement of the TCR by low affinity ligands. J Immunol 150:1-7
43. Ruppert J, Alexander J, Snoke K, Coggeshall M, Herbert E, McKenzie D, Grey H, Sette A (1993) Effect of TCR antagonism on interaction between T cells and APCs on T cell signalling events. Proc Natl Acad Sci USA 90:260-263
44. Evavold B, Sloan-Lancaster J, Allen P (1994) Antagonism of superantigen stimulated helper T cell clones and hybridomas by APL. Proc Natl Acad Sci USA 91:2300-2304
45. Yoon ST, Diazani U, Bottomly K, Janeway C (1995) Both High and Low avidity antibodies to the TCR can have agonist and antagonist activities. Immunity 1:563-569
46. Sloan-Lancaster J, Evavold B, Allen P (1993) Induction of T cell anergy by altered TCR ligand on live APCs. Nature 363:156-159
47. Sloan-Lancaster J, Evavold B, Allen P (1994) TH2 cell clonal anergy as a consequence of partial activation. J Exp Med 180:1195-1205
48. Hollsberg P, Weber W, Dangond F, Batra V, Sette A, Hafler D (1995) Differential activation of proliferation and cytotoxicity in HTLV-1 Tax specific CD* T cells by an altered peptide ligand. Proc Natl Acad Sci USA 92:4036-4040
49. Jameson SC, Carbone FR, Bevan MJ (1993) Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med 177:1541-1550
50. Bertoletti A, Sette A, Chisari F, Penna A, Levrero M, De Carli M, Fiaccadori F, Ferrari C (1994) Natural variants of cytotoxic epitopes are TCR antagonists for antiviral CTL. Nature 369:403-410
51. Klenerman P, Rowland-Jones S, McAdam S, Edwards J, Daenke S, Lalloo D, Koppe B, Rosenberg W, Boyd D, Edwards A, Giangrande P, Phillips RE, McMichael AJ (1994) CTL activity antagonised by naturally occurring HIV-1 gag variants. Nature 369:403-407
52. Madrenas J, Wange R, Wang J, Samelson L, Germain R (1995) Zeta phosphorylation without zap 70 activation induced by TCR antagonists or partial agonists. Science 267:515-519
53. Sloan-Lancaster J, Shaw A, Rothbard J, Allen P (1994) Partial T cell signalling; altered phospho-zeta and lack of Zap-70 recruitment in APL-induced T cell anergy. Cell 79:931-942
54. Zinkernagel R, Allen P (1994) Promethean viruses. Nature 369:355-356
55. Klenerman P, Meier U-C, Phillips R, McMichael A (1995) Altered Peptide Ligands and the whole blood CTL response to HIV-1. Eur J Immunol 25:1927-1931
56. Fazekas de St Groth S, Webster RG (1996) Disquisitions on the phenomenon of Original Antigenic Sin: Evidence in Man. J Exp Med 124:331-336
57. Goudsmit J, Back NKT, Nara PL (1991) Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development. FASEB J 5:2427-2436
58. Meier V-C, Kleyerman P, Griffin P, James W, Köppe B, Larder B, McMichael A, Phillips R (1995) Cytotoxic T Lymphocyte lysis inhibited by Viable HIV Mutants. Science 270:1360-1362
59. Zhang W, Hockley D, Nermut M, Jones I (1994) Functional consequences of mutations in the CA domain of p55 gag selected by CLT pressure. Virology 203:101-105
60. Bukrinsky M, Haggerty S, Dempsey M, Sharova N, Adzubei A, Spitz L, Law P, Golfarb D, Emmerson M, Stevenson M (1993) A nuclear localisation signal that governs infection of non-dividing cells. Nature 365:666-669
61. Nowak M, May R, Phillips R, Lalloo D, Rowland-Jones S, McAdam S, Klenerman P, BK, Bangham C, McMichael A (1995) Antigenic Oscillation and shifting Immunodominance in HIV. Nature 375:606-611